|
Product:
|
MDV3100 ( Enzalutamide ) |
|
Catalog Number:
|
111366 |
|
CAS Number:
|
915087-33-1 |
|
Synonyms:
|
Enzalutamide, MDV3100, MDV-3100, MDV 3100;
Chemical Name: 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide |
|
Pricing:
|
|
|
Formula:
|
C21H16F4N4O2S |
|
Molecular Weight:
|
464.4 |
|
Structure:
|
|
|
Appearance:
|
Solid |
|
Category:
|
Nucleotides and Nucleosides Alphabetic Listing |
|
Solubility:
|
≥23.22 mg/mL in DMSO; insoluble in H2O; ≥9.44 mg/mL in EtOH |
|
Transportation:
|
Ships on blue ice |
|
Literature References:
|
Manoj P. Menon, Celestia S. Higano. Enzalutamide, a Second Generation Androgen Receptor Antagonist: Development and Clinical Applications in Prostate Cancer. Current Oncology Reports. 2013; 15(2): 69–75. |
|
MSDS:
|
|
|
Applications:
|
MDV3100, known as Enzalutamide, is a second-generation androgen receptor (AR) signaling inhibitor. It has been demonstrated impressive affinity to the AR compared to the first-generation AR inhibitors. |
Inquire About a Product